KRAS and neoplasm: Additionally, it has been reported that the L1 cell adhesion molecule (L1CAM) is overexpressed in patients with metastatic colorectal cancer, suggesting its possible role in tumor aggressiveness; however, further studies are needed to fully elucidate its mechanistic relationship with KRAS mutations and its potential as a therapeutic target [24].